Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types

Cancer Research

Volumn 69, Issue 18, 2009, Pages 7188-7197

  Cadieux, Chantal ^a,b   Kedinger, Valérie ^a   Yao, Lu ^a,b   Vadnais, Charles ^a,b   Drossos, Maria ^a   Paquet, Marilène ^a   Nepveu, Alain ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P110; PROTEIN P75; SHORT HAIRPIN RNA; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; FEMALE; GENE OVEREXPRESSION; LONG TERMINAL REPEAT; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; TRANSCRIPTION REGULATION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CARCINOMA, ADENOSQUAMOUS; CASEINS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RECEPTOR, ERBB-2; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSGENES; WNT PROTEINS;

EID: 70349728485     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4899     Document Type: Article

References (46)

1. Nepveu A. Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene 2001;270:1-15. (Pubitemid 32525797)
2. Sansregret L, Nepveu A. The multiple roles of CUX1: insights from mouse models and cell-based assays. Gene 2008;412:84-94.
3. Moon NS, Berube G, Nepveu A. CCAAT displacement activity involves Cut repeats 1 and 2, not the Cut homeodomain. J Biol Chem 2000;275:31325-31334 (Pubitemid 30757800)
4. Harada R, Berube G, Tamplin OJ, Denis-Larose C, Nepveu A. DNA-binding specificity of the cut repeats from the human cut-like protein. Mol Cell Biol 1995;15:129-140 (Pubitemid 24379909)
5. Moon NS, Premdas P, Truscott M, Leduy L, Berube G, Nepveu A. S phase-specific proteolytic cleavage is required to activate stable DNA binding by the CDP/Cut homeodomain protein. Mol Cell Biol 2001;21:6332-6345 (Pubitemid 34263531)
6. Goulet B, Watson P, Poirier M, et al. Characterization of a tissue-specific CDP/Cux isoform, p75, activated in breast tumor cells. Cancer Res 2002;62:6625-6633
7. Harada R, Vadnais C, Sansregret L, et al. Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes. Nucleic Acids Res 2008;36:189-202.
8. Michl P, Ramjaun AR, Pardo OE, et al. CUTL1 is a target of TGF(β) signaling that enhances cancer cell motility and invasiveness. Cancer Cell 2005;7:521-532 (Pubitemid 40799246)
9. Sansregret L, Goulet B, Harada R, et al. The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase. Mol Cell Biol 2006;26:2441-2455 (Pubitemid 43346942)
10. De Vos J, Thykjaer T, Tarte K, et al. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene 2002;21:6848-6857 (Pubitemid 35221928)
11. Tsutsumi S, Taketani T, Nishimura K, et al. Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements. Cancer Res 2003;63:4882-4887 (Pubitemid 37022621)
12. Moon NS, Rong Zeng W, Premdas P, Santaguida M, Berube G, Nepveu A. Expression of N-terminally truncated isoforms of CDP/CUX is increased in human uterine leiomyomas. Int J Cancer 2002;100:429-432
13. Goulet B, Sansregret L, Leduy L, et al. Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation. Mol Cancer Res 2007;5:899-907. (Pubitemid 47416667)
14. Ledford AW, Brantley JG, Kemeny G, et al. Deregulated expression of the homeobox gene Cux-1 in transgenic mice results in downregulation of p27(kip1) expression during nephrogenesis, glomerular abnormalities, and multiorgan hyperplasia. Dev Biol 2002;245:157-171 (Pubitemid 34461811)
15. Brantley JG, Sharma M, Alcalay NI, Heuvel GBV. Cux-1 transgenic mice develop glomerulosclerosis and interstitial fibrosis. Kidney Int 2003;63:1240-1248 (Pubitemid 36349989)
16. Bronson SK, Plaehn EG, Kluckman KD, Hagaman JR, Maeda N, Smithies O. Single-copy transgenic mice with chosen-site integration [see comments]. Proc Natl Acad Sci U S A 1996;93:9067-9072 (Pubitemid 26282019)
17. Cadieux C, Fournier S, Peterson AC, Bédard C, Bedell BJ, Nepveu A. Transgenic mice expressing the p75 CCAAT-displacement protein/cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia. Cancer Res 2006;66:9492-9501 (Pubitemid 44623647)
18. Cadieux C, Harada R, Paquet M, et al. Polycystic kidneys caused by sustained expression of Cux1 isoform p75. J Biol Chem 2008;283:13817-13824
19. Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P. A versatile tool for conditional gene expression and knockdown. Nature Methods 2006;3:109-116 (Pubitemid 43173309)
20. Philippe J. The southwestern assay. Methods Mol Biol (Clifton, NJ) 1994;31:349-361
21. Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, Seldin DC. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 2001;20:3247-3257 (Pubitemid 32553677)
22. White DE, Cardiff RD, Dedhar S, Muller WJ. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 2001;20:7064-7072 (Pubitemid 33052198)
23. Rosner A, Miyoshi K, Landesman-Bollag E, et al. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol 2002;161:1087-1097 (Pubitemid 34988396)
24. Podsypanina K, Li Y, Varmus HE. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype. BMC Med 2004;2:24. (Pubitemid 39111854)
25. Huang S, Podsypanina K, Chen Y, et al. Wnt-1 is dominant over neuin specifying mammary tumor expression profiles. Technol Cancer Res Treat 2006;5:565-571 (Pubitemid 46068044)
26. Brotherick I, Robson CN, Browell DA, et al. Cytokeratin expression in breast cancer: phenotypic changes associated with disease progression. Cytometry 1998;32:301-308 (Pubitemid 28345954)
27. Woelfle U, Sauter G, Santjer S, Brakenhoff R, Pantel K. Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer. Clin Cancer Res 2004;10:2670-2674 (Pubitemid 38509140)
28. Teuliere J, Faraldo MM, Deugnier MA, et al. Targeted activation of β-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development 2005;132:267-277
29. Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, Schuler LA. Prolactin induces ERα-positive and ERα-negative mammary cancer in transgenic mice. Oncogene 2003;22:4664-4674 (Pubitemid 36976441)
30. Pirkmaier A, Dow R, Ganiatsas S, et al. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma. Oncogene 2003;22:4425-4433
31. Miyoshi K, Shillingford JM, Le Provost F, et al. Activation of β-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc Natl Acad Sci U S A 2002;99:219-224 (Pubitemid 34060344)
32. Miyoshi K, Rosner A, Nozawa M, et al. Activation of different Wnt/β-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene 2002;21:5548-5556 (Pubitemid 34983544)
33. Bergmann S, Royer-Pokora B, Fietze E, et al. YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res 2005;65:4078-4087 (Pubitemid 40775644)
34. Carboni JM, Lee AV, Hadsell DL, et al. Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res 2005;65:3781-3787
35. Dearth RK, Cui X, Kim HJ, et al. Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol 2006;26:9302-9314 (Pubitemid 44904425)
36. Romieu-Mourez R, Kim DW, Shin SM, et al. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol 2003;23:5738-5754 (Pubitemid 36951337)
37. Sum EY, Segara D, Duscio B, et al. Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer. Proc Natl Acad Sci U S A 2005;102:7659-7664 (Pubitemid 40741027)
38. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenicmice. Nature 1994;369:669-671 (Pubitemid 24199473)
39. Li Y, Welm B, Podsypanina K, et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A 2003;100:15853-15858 (Pubitemid 38021079)
40. Uyttendaele H, Soriano JV, Montesano R, Kitajewski J. Notch4 and Wnt-1 proteins function to regulate branching morphogenesis of mammary epithelial cells in an opposing fashion. Dev Biol 1998;196:204-217 (Pubitemid 28198847)
41. Lin TP, Guzman RC, Osborn RC, Thordarson G, Nandi S. Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice. Cancer Res 1992;52:4413-4419
42. Jack J, Dorsett D, Delotto Y, Liu S. Expression of the cut locus in the Drosophila wing margin is required for cell type specification and is regulated by a distant enhancer. Development 1991;113:735-747 (Pubitemid 21900313)
43. Jack J, DeLotto Y. Effect of wing scalloping mutations on cut expression and sense organ differentiation in the Drosophila wing margin. Genetics 1992;131:353-363
44. Micchelli CA, Rulifson EJ, Blair SS. The function and regulation of cut expression on the wing margin of Drosophila: Notch, Wingless and a dominant negative role for Delta and Serrate. Development 1997;124:1485-1495
45. Neumann CJ, Cohen SM. A hierarchy of cross-regulation involving Notch, wingless, vestigial and cut organizes the dorsal/ventral axis of the Drosophila wing. Development 1996;122:3477-3485
46. Li Y, Hively WP, Varmus HE. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 2000;19:1002-1009 (Pubitemid 30153783)